Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDPAL: Lisinopril vs Atenolol in Hemodialysis Hypertension
NCT00582114Phase 3Terminated
- Sponsor
- Indiana University
- Start
- Aug 2005
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lisinopril in hypertension (HTN) and left ventricular hypertrophy (LVH) (2 arms), sponsored by Indiana University. Primary endpoint: Regression of Left Ventricular Hypertrophy (LVH) by Echocardiographic Criteria at 1 year. Started Aug 2005; status: terminated.
02
Drugs
lisinopril
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00582114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582114.